PRIVIA HEALTH GROUP INC (PRVA) Stock Fundamental Analysis
USA - NASDAQ:PRVA - US74276R1023 - Common Stock
25.97 USD
+0.04 (+0.15%)
Overall PRVA gets a fundamental rating of 4 out of 10. We evaluated PRVA against 101 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. PRVA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PRVA had positive earnings in the past year.
PRVA had a positive operating cash flow in the past year.
In multiple years PRVA reported negative net income over the last 5 years.
In the past 5 years PRVA always reported a positive cash flow from operatings.
1.2 Ratios
PRVA's Return On Assets of 1.17% is in line compared to the rest of the industry. PRVA outperforms 52.48% of its industry peers.
With a Return On Equity value of 2.17%, PRVA perfoms like the industry average, outperforming 55.45% of the companies in the same industry.
The Return On Invested Capital of PRVA (1.78%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.17% | ||
| ROE | 2.17% | ||
| ROIC | 1.78% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 0.78%, PRVA perfoms like the industry average, outperforming 52.48% of the companies in the same industry.
PRVA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 1.03%, PRVA is in line with its industry, outperforming 41.58% of the companies in the same industry.
PRVA's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 9.96%, PRVA is not doing good in the industry: 73.27% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.03% | ||
| PM (TTM) | 0.78% | ||
| GM | 9.96% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRVA is destroying value.
Compared to 1 year ago, PRVA has more shares outstanding
The number of shares outstanding for PRVA has been increased compared to 5 years ago.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PRVA has an Altman-Z score of 4.92. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.92, PRVA is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.92 |
ROIC/WACC0.19
WACC9.15%
2.3 Liquidity
A Current Ratio of 1.65 indicates that PRVA should not have too much problems paying its short term obligations.
The Current ratio of PRVA (1.65) is comparable to the rest of the industry.
A Quick Ratio of 1.65 indicates that PRVA should not have too much problems paying its short term obligations.
PRVA has a better Quick ratio (1.65) than 60.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
PRVA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.33%.
Measured over the past 5 years, PRVA shows a small growth in Earnings Per Share. The EPS has been growing by 7.43% on average per year.
The Revenue has grown by 12.05% in the past year. This is quite good.
The Revenue has been growing by 17.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.33%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)12.05%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%18.53%
3.2 Future
Based on estimates for the next years, PRVA will show a very strong growth in Earnings Per Share. The EPS will grow by 59.62% on average per year.
The Revenue is expected to grow by 2.27% on average over the next years.
EPS Next Y53.99%
EPS Next 2Y72.31%
EPS Next 3Y59.62%
EPS Next 5YN/A
Revenue Next Year15.55%
Revenue Next 2Y8.04%
Revenue Next 3Y6.75%
Revenue Next 5Y2.27%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 236.09, the valuation of PRVA can be described as expensive.
Based on the Price/Earnings ratio, PRVA is valued a bit more expensive than 60.40% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.00. PRVA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 79.51 indicates a quite expensive valuation of PRVA.
PRVA's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, PRVA is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 236.09 | ||
| Fwd PE | 79.51 |
4.2 Price Multiples
62.38% of the companies in the same industry are cheaper than PRVA, based on the Enterprise Value to EBITDA ratio.
PRVA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.9 | ||
| EV/EBITDA | 100.7 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as PRVA's earnings are expected to grow with 59.62% in the coming years.
PEG (NY)4.37
PEG (5Y)31.76
EPS Next 2Y72.31%
EPS Next 3Y59.62%
5. Dividend
5.1 Amount
PRVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PRVA (10/29/2025, 11:59:03 AM)
25.97
+0.04 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners97.09%
Inst Owner Change-0.02%
Ins Owners1.85%
Ins Owner Change-0.11%
Market Cap3.19B
Revenue(TTM)1.90B
Net Income(TTM)14.84M
Analysts84.44
Price Target31.19 (20.1%)
Short Float %3.28%
Short Ratio4.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.4%
Min EPS beat(2)-60.96%
Max EPS beat(2)-37.83%
EPS beat(4)0
Avg EPS beat(4)-44.58%
Min EPS beat(4)-60.96%
Max EPS beat(4)-37.83%
EPS beat(8)0
Avg EPS beat(8)-41.13%
EPS beat(12)4
Avg EPS beat(12)50.02%
EPS beat(16)7
Avg EPS beat(16)58.25%
Revenue beat(2)2
Avg Revenue beat(2)3.24%
Min Revenue beat(2)0.75%
Max Revenue beat(2)5.73%
Revenue beat(4)4
Avg Revenue beat(4)3.97%
Min Revenue beat(4)0.75%
Max Revenue beat(4)7.92%
Revenue beat(8)8
Avg Revenue beat(8)3.27%
Revenue beat(12)9
Avg Revenue beat(12)-4.22%
Revenue beat(16)10
Avg Revenue beat(16)-9.82%
PT rev (1m)0%
PT rev (3m)-0.07%
EPS NQ rev (1m)1.32%
EPS NQ rev (3m)-13.58%
EPS NY rev (1m)1.84%
EPS NY rev (3m)-19.27%
Revenue NQ rev (1m)-6.79%
Revenue NQ rev (3m)-7.11%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 236.09 | ||
| Fwd PE | 79.51 | ||
| P/S | 1.68 | ||
| P/FCF | 32.9 | ||
| P/OCF | 34.7 | ||
| P/B | 4.67 | ||
| P/tB | 9.36 | ||
| EV/EBITDA | 100.7 |
EPS(TTM)0.11
EY0.42%
EPS(NY)0.33
Fwd EY1.26%
FCF(TTM)0.79
FCFY3.04%
OCF(TTM)0.75
OCFY2.88%
SpS15.48
BVpS5.56
TBVpS2.77
PEG (NY)4.37
PEG (5Y)31.76
Graham Number3.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.17% | ||
| ROE | 2.17% | ||
| ROCE | 2.66% | ||
| ROIC | 1.78% | ||
| ROICexc | 3.77% | ||
| ROICexgc | 251.71% | ||
| OM | 1.03% | ||
| PM (TTM) | 0.78% | ||
| GM | 9.96% | ||
| FCFM | 5.1% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score5
Asset Turnover1.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 77.53 | ||
| Cash Conversion | 331.3% | ||
| Profit Quality | 652.71% | ||
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | 4.92 |
F-Score5
WACC9.15%
ROIC/WACC0.19
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.33%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%-33.33%
EPS Next Y53.99%
EPS Next 2Y72.31%
EPS Next 3Y59.62%
EPS Next 5YN/A
Revenue 1Y (TTM)12.05%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%18.53%
Revenue Next Year15.55%
Revenue Next 2Y8.04%
Revenue Next 3Y6.75%
Revenue Next 5Y2.27%
EBIT growth 1Y52.75%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year534.36%
EBIT Next 3Y107.12%
EBIT Next 5Y64.83%
FCF growth 1Y145.73%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y132.44%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
What is the valuation status for PRVA stock?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
What is the valuation of PRIVIA HEALTH GROUP INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 236.09 and the Price/Book (PB) ratio is 4.67.
What is the earnings growth outlook for PRIVIA HEALTH GROUP INC?
The Earnings per Share (EPS) of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 53.99% in the next year.